Quarterly report pursuant to Section 13 or 15(d)

Nature of Operations and Summary of Significant Accounting and Reporting Policies (Details Narrative)

v3.19.1
Nature of Operations and Summary of Significant Accounting and Reporting Policies (Details Narrative)
3 Months Ended 9 Months Ended
Mar. 31, 2019
USD ($)
Integer
shares
Mar. 31, 2018
USD ($)
Mar. 31, 2019
USD ($)
Integer
shares
Mar. 31, 2018
USD ($)
Sep. 21, 2018
shares
Jun. 30, 2018
USD ($)
shares
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized 4,000,000,000   4,000,000,000   400,000,000 4,000,000,000
Foreign currency exchange rate translation 0.7104 0.7816 0.7104 0.7816   0.7399
Cash equivalents | $      
Value added tax receivable | $ 4,379   $ 4,379     $ 6,257
Income tax percentage description     On December 22, 2017, the passage of legislation commonly referred to as the Tax Cuts and Jobs Act ("TCJA") was enacted and significantly revised the U.S. income tax law. The TCJA includes changes, which reduce the corporate income tax rate from 34% to 21% for fiscal years beginning after December 31, 2017.      
Income tax percentage     21.00%      
Research and development costs | $ 52,655 $ 75,138 $ 203,625 $ 1,673,606    
Tax Credits | $ $ (726) $ 485 $ 116,244 $ 180,763    
Debt conversion percentage     4.99%      
Debt conversion percentage, description     Each holder of the notes has agreed to a 4.99% beneficial ownership conversion limitation, (subject to certain noteholders' ability to increase such limitation to 9.99% upon 60 days' notice to the Company)      
Stock Options [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount     572,000      
Convertible Notes Payable [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of convertible notes payable converted common shares | Integer 11   11      
Warrants [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount     29,517      
Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Antidilutive securities excluded from computation of earnings per share, amount     118,197,663      
Maximum [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized         4,000,000,000  
Weighted Average [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Foreign currency exchange rate translation 0.7203 0.7690 0.7203 0.7690   0.7753
Previously Authorized Shares [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized         400,000,000